FREE TO READ

Everything here is free to read, and nothing here is a claim about your case. Built from California’s published records and modified by us — not official government data. How these numbers were made.

Condition class · subcategory · California

Sinusitis denials at external review

When a California health plan denied care for sinusitis and the enrollee took it to Independent Medical Review, this is what independent physician reviewers decided.

86.9%

Overturned
86 of 99
Era
2021-2025
Jurisdiction
California DMHC IMR
Published class
Sinusitis
Median days to decision
45
All years
59.5% of 185
86 overturned13 upheld

What stands out here

computed from this class
  • among the highest

    At 86.9%, this is the 7th highest overturn rate of the 72 conditiones with enough decisions to publish one. Reviewers sustained the plan in the remaining 13.1% of disputes.

What reviewers relied on

3 validated codes

California requires each published decision to carry “a detailed case summary that includes the specific standards, criteria, and medical and scientific evidence, if any, that led to the case decision” (Health & Safety Code § 1374.33(h)(1)(K)). These are the elements our extraction found in this class, split by how the decision came out.

What the reviewer relied onIn overturnsIn upholds
the FDA label or approval status2%n=86
a standardised level-of-care instrument0%n=86
a California statutory definition0%n=86

Read as description, not instruction. These are patterns in what reviewers wrote, not steps to follow, and no combination of them predicts an outcome. Only codes that cleared the validation gate appear — thirteen did not.

Authorities named in this class

computed
  • FDA3
  • NCCN1

A rate here is the outcome of decisions that named the authority, not the effect of naming it. Reviewers cite the standard they applied; the citation and the outcome share a cause.

By treatment

computed
  • Overturned — the reviewer did not sustain the denial
  • Upheld — the reviewer sustained the denial
  • Ear, nose & throat procedures90.3%93
  • Pharmacy3
  • Diagnostic imaging & screening2
  • Reconstructive & plastic procedures1

Browse all treatment classes · Pick your own pair

The specific treatments inside this class

below n=30, no rate is claimed
  • Sinus Surgery90.8%76
  • Other16
  • Biologics2
  • MRI2
  • Antibiotics1
  • Rhinoplasty1
  • Septoplasty1

By review type

computed
  • Medical Necessity88.0%92
  • Experimental/Investigational7

Medical-necessity review asks whether the care is needed. Experimental/investigational review asks whether it is likely to be more beneficial than standard therapy — a harder statutory test, and the rates show it.

Every figure on this page is conditional on a denial having reached external review. Fewer than 1% of denials are appealed internally at all, so this describes denials that were fought to the end — not denials in general — and it describes California only. Who this does not cover.

Free help, first: the California DMHC Help Center files your Independent Medical Review at no cost — 1-888-466-2219, dmhc.ca.gov.